Agenus AGEN
NASDAQ AGEN
$8.26 +0.02 (+0.24%)
As of: Sep 4, 2026 · 3:21 PM EDT

Agenus (AGEN) Non-Current Deffered Revenue (2010 - 2026)

Agenus (AGEN) posted quarterly Non-Current Deffered Revenue of $1.1 million for Q1 2026, little changed year-over-year from $1.1 million in Q1 2025, and little changed quarter-over-quarter from $1.1 million in Q4 2025.

Analysis

Agenus (AGEN) Non-Current Deffered Revenue (2010 - 2026) Analysis & Trends

Agenus' Non-Current Deffered Revenue history runs 17 years deep, the most recent figure standing at $1.1 million for Q1 2026.

  • In Q1 2026, Non-Current Deffered Revenue changed 0.0% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (changed 0.0% YoY), while the FY2025 annual figure was $1.1 million, changed 0.0% from the prior year.
  • Non-Current Deffered Revenue for Q1 2026 stood at $1.1 million, roughly flat from $1.1 million in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $8.7 million in Q1 2022, with the low at $1.1 million in Q4 2022.
  • The 5-year median for Non-Current Deffered Revenue is $1.1 million (2022), against an average of $2.0 million.
  • The sharpest annual moves came in 2022 and 2023: Non-Current Deffered Revenue tumbled 89.79% in 2022, then changed 0.0% in 2023.
  • Agenus' Non-Current Deffered Revenue stood at $1.1 million in 2022, then changed by 0.0% to $1.1 million in 2023, then changed by 0.0% to $1.1 million in 2024, then changed by 0.0% to $1.1 million in 2025, then changed by 0.0% to $1.1 million in 2026.
  • Business Quant data shows AGEN's Non-Current Deffered Revenue at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 220.40 Mn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn -
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn 147.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn - -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn -
8 Royalty Pharma 28.42 Bn 27.58 Bn - -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn -
10 Agenus 341.87 Mn 341.87 Mn 34.52 Mn 1.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.14 Mn
Mar 31, 2026 1.14 Mn
Dec 31, 2025 1.14 Mn
Sep 30, 2025 1.14 Mn
Jun 30, 2025 1.14 Mn
Mar 31, 2025 1.14 Mn
Dec 31, 2024 1.14 Mn
Sep 30, 2024 1.14 Mn
Jun 30, 2024 1.14 Mn
Mar 31, 2024 1.14 Mn
Dec 31, 2023 1.14 Mn
Sep 30, 2023 1.14 Mn
Jun 30, 2023 1.14 Mn
Mar 31, 2023 1.14 Mn
Dec 31, 2022 1.14 Mn
Sep 30, 2022 3.07 Mn
Jun 30, 2022 6.17 Mn
Mar 31, 2022 8.69 Mn
Dec 31, 2021 11.20 Mn
Sep 30, 2021 5.41 Mn